Literature DB >> 7092009

Cyclophosphamide hepatotoxicity in a patient with systemic lupus erythematosus.

A M Bacon, S A Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7092009     DOI： 10.7326/0003-4819-97-1-62

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis.

Authors:  Luigi Muratori; Rodolfo Ferrari; Paolo Muratori; Alessandro Granito; Francesco B Bianchi
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 2.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27

3.  Reversible hepatic dysfunction in association with cyclophosphamide therapy.

Authors:  D V Milford; N Butler; R Clarke; J Vaid
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

Review 4.  Cyclophosphamide-induced severe acute hepatitis in a rheumatic disease: case-based review.

Authors:  Döndü Üsküdar Cansu; Erkin Öztaş; Evrim Yilmaz; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2018-10-30       Impact factor: 2.631
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.